Opus Genetics, Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Opus Genetics, Inc. stock issued during period, shares, new issues for the quarter ending 2015-12-31 was -1.27M shares.
- Opus Genetics, Inc. stock issued during period, shares, new issues for the quarter ending 2015-09-30 was 0.00 shares.
- Opus Genetics, Inc. stock issued during period, shares, new issues for fiscal 2017 was 0.00 shares.
- Opus Genetics, Inc. stock issued during period, shares, new issues for fiscal 2016 was 0.00 shares, a 100.00% decline from fiscal 2015.
- Opus Genetics, Inc. stock issued during period, shares, new issues for fiscal 2015 was 140.71K shares.
- Opus Genetics, Inc. stock issued during period, shares, new issues for fiscal 2013 was 375.00K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2017-12-31 | 0.00 shares 10-K · filed 2018-03-09 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2018-03-09 | |
| 2015-12-31 | -1.27M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | 140.71K shares 10-K · filed 2018-03-09 |
| 2015-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-02 | |
| 2013-12-31 | 375.00K shares 10-K · filed 2015-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |